Showing results (881-890 of 6,880) with videos related to
Sort By:
Pageof 688
Leukemia Research|January 1, 1992
Predicting remission outcome in acute non-lymphocytic leukemia: general principles and their application to residual marrow leukemiaG P Browman, H D PreislerLeukemia Research|October 26, 2005
Viscum album agglutinin-I (VAA-I) induces apoptosis and degradation of cytoskeletal proteins in human leukemia PLB-985 and X-CGD cells via caspases: lamin B1 is a novel target of VAA-IValérie Lavastre, Sonia Chiasson, Hélène Cavalli, et al.Leukemia Research|January 1, 1992
Four additional cases of trisomy 14 as the sole anomaly in various haematological malignanciesA Brizard, F Guilhot, P Babin, et al.Leukemia Research|February 1, 1995
Cytarabine-induced pericarditis: a case report and review of the literature of the cardio-pulmonary complications of cytarabine therapyS Reykdal, R Sham, P KouidesLeukemia Research|April 1, 1994
Transport and metabolism of polyamines in wild and multidrug resistant human leukemia (K 562) cellsN A Khan, O Fardel, R Havouis, et al.Leukemia Research|January 1, 1983
Effect of thymosin and phorbol ester on purine metabolic enzymes and cell surface phenotype in a malignant T-cell line (MOLT-3)A D Ho, D D Ma, G Price, et al.Leukemia Research|March 1, 1995
Radiotoxicity of 67-gallium on myeloid leukemic blastsA R Jonkhoff, P C Huijgens, R T Versteegh, et al.Leukemia Research|March 1, 1995
Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and WelfareS Oguma, Y Yoshida, H Uchino, et al.Leukemia Research|July 1, 1993
Reduction of the leukemogenic potential of malignant murine leukemic cells by in vivo treatment with recombinant human granulocyte colony-stimulating factorM Tamura, T Orita, M Oh-eda, et al.Pageof 688